Alkermes
ALKS
#3196
Rank
HK$35.78 B
Marketcap
HK$216.75
Share price
-1.10%
Change (1 day)
-9.11%
Change (1 year)

Alkermes (ALKS) - P/B ratio

P/B ratio as of December 2025 : 2.66

According to Alkermes's latest financial reports the company has a price-to-book ratio of 3.02865.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Alkermes - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-312.71-16.82%
2024-12-313.26-15.21%
2023-12-313.85-6.43%
2022-12-314.1121.68%
2021-12-313.3813.61%
2020-12-312.980.35%
2019-12-312.97-24.44%
2018-12-313.92-43.92%
2017-12-317.000.19%
2016-12-316.98-23.27%
2015-12-319.1047.16%
2014-12-316.1912.27%
2013-12-315.51106.66%
2012-12-312.677.23%
2011-12-312.49-15.83%
2010-12-312.9539.37%
2009-12-312.12-5.99%
2008-12-312.25-44.57%
2007-12-314.07-42.08%
2006-12-317.02-91.14%
2005-12-3179.317.35%
2004-12-3167.6455.15%
2003-12-3112.274.58%
2002-12-316.97

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Acorda Therapeutics
ACOR
-0.0044-100.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
5.88 121.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
6.36 139.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1.53-42.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
6.11 129.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
4.77 79.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Sanofi
SNY
1.34-49.61%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
5.78 117.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland